Related Experiment Videos
[CD40 as a mediator of proliferation in normal ans neoplastic thymic epithelium]
A Schultz1, A Greiner, R Nenninger
1Institute of Pathology, University of Würzburg.
Insights
CD40 is active in the human thymus, promoting proliferation of normal and tumor thymic epithelial cells. This suggests CD40’s role in thymoma-associated tolerance breakdown.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- CD40 is crucial for B-cell function but its role in the human thymus is unclear.
- Investigating CD40's function in thymic epithelial cells and tumors is necessary.
Purpose of the Study:
- To determine if CD40 is functionally active in the human thymus.
- To assess CD40's role in thymic epithelial cell proliferation in normal and neoplastic states.
Main Methods:
- Cultured primary normal and neoplastic thymic epithelial cells.
- Measured cell proliferation via 3H-Thymidine incorporation after CD40 ligand (CD40L) stimulation.
- Used CD40L-specific monoclonal antibody to confirm specificity.
Main Results:
- Normal thymic epithelial cells proliferated in response to CD40L in a dose-dependent manner.
- CD40L-induced proliferation was blocked by a specific antibody.
- Neoplastic thymic epithelial cells from thymomas showed similar proliferation responses.
Conclusions:
- CD40 is expressed and functional on normal and neoplastic thymic epithelial cells in vitro.
- CD40 signaling influences thymic epithelial cell proliferation.
- Differential CD40 expression in thymomas suggests a role in tolerance disruption.
Aims And Methods:
While CD40 is a costimulatory molecule of utmost importance for B-cell proliferation and Ig class switch its role has not been elucidated in the human thymus and in thymic epithelial tumors. To investigate, whether CD40 is functionally active there, we investigated the proliferative response by 3H-Thymidin incorporation of primary normal and neoplastic thymic epithelial cell cultures to CD40 triggering by soluble CD40 ligand (CD40L).
Results:
Normal thymic epithelial cells exhibited proliferation in response to CD40 ligand in a dose dependent manner, while a CD40 ligand specific monoclonal antibody prevented this effect. This response was not significantly different from the response of neoplastic thymic epithelial cells derived from myasthenia gravis-associated thymomas.
Conclusion:
Our data demonstrate that CD40 is expressed on the surface of normal and neoplastic epithelial cells of the thymus and is a functional molecule in terms of epithelial cell proliferation in vitro. Given the differential expression of CD40 in the various histological thymoma subtypes in vivo, the finding suggests a role of CD40 in the different mechanisms of tolerance breakdown in thymomas.